19473-96-2

Basic information

• Product Name: 1-methyl 4-(2-carboxyvinyl)benzoate
• Synonyms: 1-methyl 4-(2-carboxyvinyl)benzoate;4-Methoxycarbonylbenzenepropenoic acid;Benzoic acid, 4-(2-carboxyethenyl)-, 1-methyl ester;Benzoic acid, 4-(2-carboxyethenyl)-, methyl ester;Einecs 243-095-6;4-(2-Carboxyethenyl)benzoic Acid Methyl Ester
• CAS NO: 19473-96-2
• Molecular Formula: C₁₁H₁₀O₄
• Molecular Weight: 206.1947
• EINECS: 243-095-6
• Product Categories: Aromatics, Intermediates
• Mol File: 19473-96-2.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 374.5°Cat760mmHg
• Flash Point: 148.5°C
• Appearance: /
• Density: 1.265g/cm³
• Vapor Pressure: 2.84E-06mmHg at 25°C
• Solubility: Ethyl Acetate, Methanol
• CAS DataBase Reference: 1-methyl 4-(2-carboxyvinyl)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: 1-methyl 4-(2-carboxyvinyl)benzoate(19473-96-2)
• EPA Substance Registry System: 1-methyl 4-(2-carboxyvinyl)benzoate(19473-96-2)

Safety Data

• Hazardous Substances Data: 19473-96-2(Hazardous Substances Data)

Usage

Description

1-methyl 4-(2-carboxyvinyl)benzoate is an organic compound that serves as an intermediate in the synthesis of heteropolycyclic quinolones. It is a white solid with unique chemical properties that make it valuable in various applications across different industries.

Uses

Used in Pharmaceutical Industry:
1-methyl 4-(2-carboxyvinyl)benzoate is used as a key intermediate for the production of heteropolycyclic quinolones, which are important compounds in the pharmaceutical industry. These quinolones possess potent antimicrobial and anti-inflammatory properties, making them useful in the development of new drugs to treat bacterial infections and inflammation-related conditions.
Used in Chemical Synthesis:
As a white solid with specific chemical properties, 1-methyl 4-(2-carboxyvinyl)benzoate can be utilized in various chemical synthesis processes. Its versatility allows it to be a valuable component in the creation of a wide range of chemical products, from pharmaceuticals to specialty chemicals.
Used in Research and Development:
Due to its role in the synthesis of heteropolycyclic quinolones, 1-methyl 4-(2-carboxyvinyl)benzoate is also used in research and development settings. Scientists and researchers can leverage its properties to explore new avenues in drug discovery, material science, and other related fields.

InChI:InChI=1/C11H10O4/c1-15-11(14)9-5-2-8(3-6-9)4-7-10(12)13/h2-7H,1H3,(H,12,13)/p-1/b7-4+

Upstream product

• 141-82-2 malonic acid 
• 1571-08-0 methyl 4-formylbenzoate 
• 188979-84-2 methyl 4-(2-t-butoxycarbonylvinyl)benzoate 
• 110-89-4 piperidine 
• 73166-52-6 4-(3-oxo-1-propen-1-yl)benzoic acid methyl ester 
• 619-66-9 4-Carboxybenzaldehyde 

Downstream Products

• 113100-81-5 4-(3-oxo-propyl)-benzoic acid methyl ester 
• 151937-09-6 3-(4-methoxycarbonylphenyl)propanoic acid 
• 137281-39-1 C₁₅H₁₄N₄O₃ 

Relevant articles and documents

Histone deacetylase inhibitor as well as preparation and application thereof

The invention relates to a histone deacetylase inhibitor and preparation and an application thereof, in particular to a novel histone deacetylase inhibitor based on a beta-elemene structure and a preparation method thereof, and further relates to an intermediate for synthesizing the histone deacetylase inhibitor and a preparation method thereof. The invention also relates to an application of the histone deacetylase inhibitor in preparation of antitumor drugs, and belongs to the technical field of chemical synthesis of drugs. The zinc ion combined compound and the salt or solvate thereof are shown as a general formula (I) or (II), wherein R, X, n and i are described in the claims and the specification.

Acrylamide benzoazepine derivatives as GSK-3beta inhibitors and applications thereof

The invention belongs to the technical field of medicinal chemistry, and discloses acrylamide benzoazepine derivatives serving as glycogen synthase kinase-3beta (GSK-3beta) inhibitors and applicationsof the acrylamide benzoaza derivatives. The derivatives are compounds shown as a formula (I) or pharmaceutically acceptable salts thereof. The compounds have good inhibitory activity on GSK-3beta andcan be used as selective inhibitors for preventing and treating GSK-3beta-related diseases, and the GSK-3beta-related diseases include cancer, neurodegenerative diseases and diabetes.

Five-membered azole-containing heterocyclic chalcone derivative, and preparation method and medical use thereof

The invention discloses a five-membered azole-containing heterocyclic chalcone derivative, and a preparation method and a medical use thereof. The five-membered azole-containing heterocyclic chalconederivative is represented by general formula (I) shown in the description, and R1 in the is formula (I) is any one of formulas also shown in the description. A result of antitumor cell proliferation activity detection shows that the above compound has a certain inhibitory effect on the proliferation of lung cancer A549 and breast cancer MCF-7 cells, and can be used as an antitumor drug.